STREAMEX CORP. Revenue from Contract with Customer, Excluding Assessed Tax
STREAMEX CORP. (STEX) reported Revenue from Contract with Customer, Excluding Assessed Tax of $146.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-14
- STREAMEX CORP. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $146.00K.
- STREAMEX CORP. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-12-31 was $13.00K, a 8.33% increase year-over-year.
- STREAMEX CORP. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- STREAMEX CORP. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-06-30 was $13.00K.
- STREAMEX CORP. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $40.00K, a 122.22% increase from fiscal 2023.
- STREAMEX CORP. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $18.00K.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $146.00K 10-Q · filed 2026-08-14 | $146.00K 10-Q · filed 2026-08-14 | ||
| 2024-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $13.00K derived: sum of 2 quarters · filed 2026-03-31 | $26.00K derived: sum of 3 quarters · filed 2026-03-31 | $40.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $13.00K derived: sum of 2 quarters · filed 2025-11-14 | $27.00K 10-Q · filed 2025-11-14 | $39.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $13.00K 10-Q · filed 2025-08-15 | $27.00K 10-Q · filed 2025-08-15 | $39.00K derived: sum of 3 quarters · filed 2025-08-15 | $40.00K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-03-31 | $14.00K 10-Q · filed 2025-05-19 | $26.00K derived: sum of 2 quarters · filed 2025-05-19 | $27.00K derived: sum of 3 quarters · filed 2025-05-19 | |
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $13.00K derived: sum of 2 quarters · filed 2025-04-15 | $18.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.00K 10-Q · filed 2024-11-14 | $6.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |